Selinexor (KPT-330) is a small molecule inhibitor of CRM1 with selective and oral activity. Selinexor blocks the cell cycle, induces apoptosis, and has antitumor activity for the treatment of multiple myeloma.
Molecular Weight:
443.31
Purity:
>99.99%
CAS Number:
[1393477-72-9]
Formula:
C17H11F6N7O
Target:
CRM1
T6106
* VAT and and shipping costs not included. Errors and price changes excepted